Susan D. DeVore bought $375K of Elevance Health (ELV)
Executed Aug 19 2025, disclosed Aug 21 2025, 2 days later.
Over the 21 trading sessions from the disclosed entry session (Aug 21 2025), the stock returned +1.7% (delay-adjusted); from the execution session (Aug 19 2025), -0.0%. Derived: entry at the session's open, exit at the close 20 sessions later.
Susan D. DeVore (Director) filed 2 Form 4 reports in the past 24 months (1 purchase, 1 sale), most often in Elevance Health, Inc. (ELV). Across 1 priced purchase filing, the average 21-session return was -0.0% from execution and +1.7% from disclosure (delay-adjusted; derived). The largest single filing was $809K of UNM (10,000 sh across 2 lots, as filed), executed Mar 3 2025.
Healthcare · Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→